Equities

Inspiration Healthcare Group PLC

IHC:LSE

Inspiration Healthcare Group PLC

Health CareMedical Equipment and Services
  • Price (GBX)17.00
  • Today's Change-0.50 / -2.86%
  • Shares traded168.56k
  • 1 Year change11.48%
  • Beta1.0341
Data delayed at least 20 minutes, as of Feb 06 2026 16:17 GMT.
More ▼

Forecasts data is unavailable for this security.

Consensus recommendation

  • 20-Feb-25
  • 20-Nov-25
  • 18-Dec-25
  • 15-Jan-26
  • 05-Feb-26
Select bar for recommendation details.
Recommendations05-Feb-26
Buy2
Outperform0
Hold0
Sell0
Strong Sell0

Share price forecast

The 2 analysts offering 12 month price targets for Inspiration Healthcare Group PLC have a median target of 56.00, with a high estimate of 82.00 and a low estimate of 30.00. The median estimate represents a 229.41% increase from the last price of 17.00.
High382.4%82.00
Med229.4%56.00
Low76.5%30.00

Earnings history & estimates

Inspiration Healthcare Group PLC reported annual 2025 losses of -2.72 per share on May 28, 2025.
Average growth rate-22.18%
More ▼

Revenue history & estimates

Inspiration Healthcare Group plc had revenues for the full year 2025 of 38.25m. This was 1.65% above the prior year's results.
Average growth rate+1.09%
More ▼
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.